Is oxytocin a therapeutic factor for ischemic heart disease?

Preconditioning signaling pathways model for oxytocin. Our data suggest that these pathways involve an amplification loop leading to IP3/DAG and NO activation and subsequent PKC activation, and constant mitoKATP opening and mPTP closing. In fine, this could result in decrease of mitochondrial membrane potential and cardioprotection.